Microscopic visualization of virus removal by dedicated filters used in biopharmaceutical processing: Impact of membrane structure and localization of captured virus particles DOI Link Author Adan-Kubo, J., et al. Organization Japanese Blood Products Organization, Asahi Kasei Medical Co., Ltd. Journal Biotechnol Progress.2019;35:e2875 Year 2019 Access Open
The Role of Nanofiltration in the Pathogen Safety of Biologicals: An Update DOI Link Author Inouye, M. and Burnouf, T. Organization M.I.: Asahi Kasei Medical Co., Ltd., T.B.: Taipei Medical University Journal Current Nanoscience, 2019, 15, 1-10 Year 2019 Access Open
Inactivation and Removal of Chikungunya Virus and Mayaro Virus from Plasma-derived Medicinal Products DOI Link Author Yue, C., et al. Organization Paul-Ehrlich-Institut, Asahi Kasei, Instituto Oswaldo Cruz Journal Viruses. 2019 Mar; 11(3): 234. Year 2019 Access Open
Use of a noninfectious surrogate to predict minute virus of mice removal during nanofiltration DOI Link Author Cetlin, D., et al Organization MockV Solutions, Inc. Journal Biotechnology Progress 34(5) pp.1113-1220 Year 2018 Access Abstract Only
Inactivation and removal of Zika virus during manufacture of plasma‐derived medicinal products DOI Link Author Blumel, J. et al Organization Paul-Ehrlich-Institut Journal Transfusion 2017 (57) 790-796 Year 2017 Access Open
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate DOI Link Author Dey, A., et al Organization International AIDS Vaccine Initiative, Department of Microbiology and Immunology, et al Journal Biotechnology and Bioengineering 2018 (115) 885–899 Year 2018 Access Open
Hepatitis E virus derived from different sources exhibits different behaviour in virus inactivation and/or removal studies with plasma derivatives DOI Link Author Yunoki, M., et al Organization Japan Blood Products Organization Journal Biologicals 44(5) 403-411 Year 2016 Access Abstract Only
Pathogen safety of a pasteurized four‐factor human prothrombin complex concentrate preparation using serial 20N virus filtration DOI Link Author Nowak, T., et al Organization CSL Behring Journal Transfusion 57(5) 1184-1191 Year 2017 Access Open
Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid DOI Link Author Radomski, K., et al Organization Octapharma Biopharmaceuticals GmbH Journal BioDrugs (2017) 31: 125 Year 2017 Access Open
Evaluation of the virus clearance capacity and robustness of the manufacturing process for the recombinant factor VIII protein, turoctocog alfa DOI Link Author Ellgaard, T., et al Organization Novo Nordisk A/S Journal Protein Expression and Purification 129 (2017) 94-100 Year 2017 Access Open